胰岛素样生长因子结合蛋白2(IGFBP2)真核蛋白
Eukaryotic Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
IBP2; IGF-BP53
- 编号EPA053Mu61
- 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
- 来源真核表达
- 宿主293F cell
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量56.8kDa
- 实际分子量70kDa(差异分析请参阅说明书)
- 片段与标签Ala34~Gln305 with N-terminal His Tag and C-terminal Fc Region of Human IgG1
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性状冻干粉
- 纯度> 95%
- 等电点7.3
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1488 ¥ 3720 ¥ 7440 ¥ 22320 ¥ 55800
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) |
APA053Mu61 | 胰岛素样生长因子结合蛋白2(IGFBP2)活性蛋白 | Cell culture; Activity Assays. |
RPA053Mu01 | 胰岛素样生长因子结合蛋白2(IGFBP2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA053Mu01 | 胰岛素样生长因子结合蛋白2(IGFBP2)活性蛋白 | Cell culture; Activity Assays. |
EPA053Mu61 | 胰岛素样生长因子结合蛋白2(IGFBP2)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA053Mu05 | 胰岛素样生长因子结合蛋白2(IGFBP2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA053Mu02 | 胰岛素样生长因子结合蛋白2(IGFBP2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA053Mu03 | 胰岛素样生长因子结合蛋白2(IGFBP2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA053Mu04 | 胰岛素样生长因子结合蛋白2(IGFBP2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA053Mu01 | 胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体 | WB; IHC; ICC; IP. |
PAA053Mu06 | 胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体 | WB; IHC; ICC; IP. |
LAA053Mu71 | 胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体(生物素标记) | WB; IHC; ICC. |
SEA053Mu | 胰岛素样生长因子结合蛋白2(IGFBP2)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA053Mu | 胰岛素样生长因子结合蛋白2(IGFBP2)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
British journal of cancer | A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. [pubmed:28664912] |
Experimental and Therapeutic Medicine | Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D‑LC‑MS/MS [Doi: 10.3892/etm.2018.6818] |
Nutrition and Cancer | Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer [Pubmed: 32286106] |
留言咨询